Purdue University-Main Campus · PharmacologyZhou Aerosol Lab
Qi Zhou · West Lafayette, Indiana
Research Focus
Dr. Qi Zhou's lab focuses on improving treatments for serious lung infections caused by multidrug-resistant bacteria, known as 'superbugs.' They are developing more effective ways to deliver antibiotics directly to the lungs using innovative aerosol systems, while minimizing side effects and preventing bacteria from becoming resistant. Their work combines advanced technologies like imaging and machine learning with pharmacological research to enhance patient outcomes in pulmonary medicine.
pulmonary infectionsmultidrug-resistant bacteriaaerosol therapypolymyxin antibioticsdrug delivery systems
Research Aims
4AIM 01Investigate how aminoglycosides reduce toxicity of polymyxins in lung cells.
AIM 02Create advanced aerosol delivery systems for polymyxin antibiotic combinations.
AIM 03Explore interactions among lung cells, pathogens, and antibiotics using multi-omics.
AIM 04Optimize inhaled polymyxin dosages using a data-driven modeling approach.
Skills the Lab Values
aerosol drug therapyCRISPRadvanced imaging techniquestranscriptomicsmachine learningmicrobial biofilm analysiscell culturein vitro testingpharmacokineticsmultiple omics approach
Output against the department
Publications725top 4% of dept.19th of 462
this lab
most publishedleast published
Citations30ktop 10% of dept.45th of 462
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.